combination therapy group:Rosuvastatin 10mg + ezetimibe 10mg

2 trials

Sponsors

Second Affiliated Hospital of Chongqing Medical University

Conditions

HBV carriers with cardiovascular risk factors in patients with lipid-lowering therapyPatients with acute coronary syndrome and lipid nonattainment

Phase 4

acute coronary syndrome patients treated with different lowwing-lipid therapies, a randomized controlled clinical trial

RecruitingChiCTR-IPR-15006636

Second Affiliated Hospital of Chongqing Medical UniversityPatients with acute coronary syndrome and lipid nonattainment

Start: 2015-07-01Updated: 2017-04-18

Unknown Phase

Rosuvastatin combined with ezetimibe in patients at high risk for cardiovascular safety and efficacy evaluation of combined hepatitis B virus carriers

RecruitingChiCTR-TRC-14005056

Second Affiliated Hospital of Chongqing Medical UniversityHBV carriers with cardiovascular risk factors in patients with lipid-lowering therapy

Start: 2014-08-01Updated: 2017-04-18